Vimta Labs Limited

Healthcare›Healthcare›Healthcare Services›Healthcare Research, Analytics & Technology

Ask AI

Key metrics

Price as of 2026-07-20

Stock price
₹530.25
Market cap
2,360 Cr
Stock P/E
31.6
P/B
5.69
Dividend yield
0.2%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricMar 2023Jun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025
Sales82 Cr83 Cr73 Cr82 Cr80 Cr82 Cr85 Cr90 Cr94 Cr98 Cr102 Cr99 Cr
Operating expenses (approx.)57 Cr58 Cr55 Cr59 Cr55 Cr57 Cr54 Cr56 Cr60 Cr62 Cr65 Cr64 Cr
EBITDA25 Cr25 Cr18 Cr23 Cr25 Cr25 Cr31 Cr34 Cr35 Cr35 Cr37 Cr34 Cr
OPM %30.4%30.2%24.4%27.8%31.3%30.8%36.1%38.2%36.7%36.3%36.2%34.9%
Other income0.67 Cr0.59 Cr2 Cr0.90 Cr0.49 Cr0.69 Cr0.68 Cr1 Cr2 Cr2 Cr3 Cr2 Cr
Interest0.25 Cr0.44 Cr0.61 Cr0.54 Cr0.53 Cr0.48 Cr0.41 Cr0.58 Cr0.44 Cr0.32 Cr0.37 Cr0.16 Cr
Depreciation8 Cr8 Cr9 Cr9 Cr8 Cr8 Cr8 Cr10 Cr9 Cr10 Cr10 Cr11 Cr
Profit before tax17 Cr16 Cr8 Cr14 Cr16 Cr17 Cr22 Cr24 Cr25 Cr25 Cr26 Cr23 Cr
Tax %23.4%25.2%24.6%25.0%24.2%25.7%22.3%26.8%26.8%25.2%24.2%24.8%
Net profit13 Cr12 Cr6 Cr10 Cr12 Cr12 Cr15 Cr21 Cr18 Cr19 Cr20 Cr18 Cr
EPS (₹)₹5.73₹5.51₹2.85₹4.57₹5.58₹5.54₹6.88₹9.65₹8.22₹4.25₹4.46₹3.96

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales181 Cr211 Cr278 Cr318 Cr318 Cr344 CrSign in for TTM
Operating expenses (approx.)148 Cr157 Cr198 Cr223 Cr231 Cr218 CrSign in for TTM
EBITDA33 Cr54 Cr81 Cr95 Cr87 Cr126 CrSign in for TTM
OPM %18.2%25.5%28.9%29.8%27.3%36.7%Sign in for TTM
Other income3 Cr0.83 Cr1 Cr3 Cr4 Cr4 CrSign in for TTM
Interest4 Cr2 Cr1 Cr3 Cr2 Cr2 CrSign in for TTM
Depreciation21 Cr23 Cr23 Cr31 Cr34 Cr35 CrSign in for TTM
Profit before tax8 Cr29 Cr56 Cr65 Cr54 Cr89 CrSign in for TTM
Tax %17.2%25.0%25.8%25.9%24.7%25.0%Sign in for TTM
Net profit7 Cr21 Cr41 Cr48 Cr41 Cr67 CrSign in for TTM
EPS (₹)₹3.10₹9.68₹18.70₹21.77₹18.51₹30.28Sign in for TTM
Dividend payout %——10.7%9.2%10.8%6.6%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity capital4 Cr4 Cr4 Cr4 Cr4 Cr4 Cr
Reserves168 Cr190 Cr230 Cr277 Cr315 Cr374 Cr
Borrowings———15 Cr19 Cr5 Cr
Other liabilities———66 Cr61 Cr82 Cr
Total liabilities———362 Cr400 Cr467 Cr
Fixed assets (net)———157 Cr156 Cr224 Cr
CWIP———12 Cr59 Cr38 Cr
Investments———0.0000 Cr0.0000 Cr0.0000 Cr
Other assets———164 Cr158 Cr188 Cr
Total assets———362 Cr400 Cr467 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from operating activity——59 Cr88 Cr61 Cr95 Cr
Cash from investing——-38 Cr-57 Cr-76 Cr-76 Cr
Cash from financing——-17 Cr-11 Cr-2 Cr-17 Cr
Net cash flow——5 Cr20 Cr-17 Cr2 Cr
Free cash flow (OCF − Capex)——29 Cr40 Cr-15 Cr16 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
ROCE %7.0%15.8%24.4%21.6%15.5%23.7%
ROE %4.0%11.0%0.0%0.0%0.0%17.8%
Debtor days———92100—
Inventory days———112118128
Days payable———7139—
Cash conversion cycle———132179128
Debt / equity———0.050.060.01
Current ratio———2.862.912.92
Net debt / EBITDA0.000.000.00-0.160.07-0.08

Compare with peers

Loading peers…